Intrathecal Chemotherapy in India

Intrathecal chemotherapy delivers selected anticancer medicine directly into cerebrospinal fluid (CSF) around the brain and spinal cord. It is used when cancer cells are present in, or at significant risk of reaching, the central nervous system, and when bloodstream dosing would not reach CSF in an adequate concentration.

There is a named GAF Healthcare partner planning sheet for intrathecal chemotherapy: $3,000–$10,000, typically day-care lumbar puncture or Ommaya access. Neighbouring United States comparison figures on the same sheet are $15,000–$40,000. That India band is a pathway planning range for oncology review, protocol planning, repeated administrations, CSF monitoring and associated hospital care. It is not the price of a single spinal injection.

Neighbouring chemotherapy is $1,500–$8,000+, typically outpatient cycles over 3–6 months. Named chemotherapy lists sit on Chemotherapy in India. Neighbouring immunotherapy is $15,000–$45,000. Neighbouring targeted therapy is $8,000–$30,000. Neighbouring maintenance therapy is $4,000–$18,000. Neighbouring CAR-T cell therapy is $80,000–$180,000 (typically apheresis plus 3–6 weeks nearby). Neighbouring bone marrow transplantation is $25,000–$70,000 (typically 4–8 weeks in or near the unit). Neighbouring hematopoietic stem cell transplantation is $22,000–$65,000.

Intrathecal dosing is almost never the whole cancer plan. Acute lymphoblastic leukaemia, selected lymphoma protocols and some leptomeningeal presentations may include CNS-directed medicine alongside systemic treatment. See leukemia treatment in India, lymphoma treatment in India, CAR-T cell therapy in India, bone marrow transplant in India and stem cell transplantation in India when those pathways sit beside CSF-directed drug.

Important: Intrathecal chemotherapy is a specialised oncology procedure. The actual hospital quotation depends on cancer type, protocol, medicine, number of administrations, lumbar puncture versus Ommaya reservoir access, CSF testing and whether systemic treatment, radiation or transplant is also required. A quotation should be obtained only after records review.

What is intrathecal chemotherapy?

Intrathecal chemotherapy is a method of delivering anticancer medicine directly into CSF. Conventional intravenous chemotherapy circulates through the bloodstream. The blood–brain barrier can limit how much of some medicines reaches the central nervous system.

Intrathecal treatment therefore allows selected medicines to be placed directly into CSF when this approach is appropriate for the patient's cancer and protocol. Administration may be through a lumbar puncture or, in selected patients who need repeated access, through an implanted Ommaya reservoir.

The procedure is generally one component of a broader oncology plan rather than an isolated injection.

Intrathecal chemotherapy cost in India at a glance

Parameter	Details
GAF Healthcare India planning	$3,000–$10,000 for the named pathway
Neighbouring United States comparison	$15,000–$40,000
Typical stay on the cost sheet	Day-care LP or Ommaya access
Common route	Lumbar puncture
Alternative route	Ommaya reservoir after neurosurgical placement
Common medicines	Methotrexate, cytarabine and selected protocol combinations
Common settings	Selected leukaemia, lymphoma and leptomeningeal presentations
Number of treatments	Protocol-dependent; not a single fixed count
Main cost drivers	Drug, access route, CSF testing, session count, hospital category and complications
Final quotation	Prepared after clinical review

These figures are indicative planning ranges rather than fixed hospital tariffs. The medicine itself can vary, and the parent cancer treatment often accounts for a much larger share of expenditure.

Why is this route used?

The central nervous system is protected by the blood–brain barrier. That barrier is important, but it can also keep some bloodstream medicines from reaching CSF in adequate concentrations.

Depending on the disease, treatment may be given for:

• Cancer already present in CSF
• Prevention of CNS involvement
• Leptomeningeal disease
• CNS-directed treatment in selected leukaemia protocols
• CNS-directed treatment in selected lymphoma protocols

It is not appropriate for every cancer patient. The decision depends on diagnosis, risk of CNS involvement, CSF findings, imaging, neurological status and the overall protocol.

Which cancers may require it?

Acute lymphoblastic leukaemia

Acute lymphoblastic leukaemia (ALL) is one of the major conditions in which CNS-directed therapy may form part of the plan. Medicine may be used to treat leukaemia involving the CNS or to reduce the risk of CNS relapse. Schedules differ by age, subtype, risk classification, CSF findings and protocol. See leukemia treatment in India.

Acute myeloid leukaemia

Intrathecal chemotherapy may be considered when AML has spread to the central nervous system. The haematology-oncology team decides according to the individual situation.

Lymphoma

Selected patients with lymphoma may receive CNS-directed medicine either to treat involvement or as prophylaxis when the risk of spread is considered significant. This can be relevant in selected aggressive subtypes, including some Burkitt presentations. See lymphoma treatment in India.

Leptomeningeal disease

Leptomeningeal disease occurs when cancer cells spread to the membranes and CSF surrounding the brain and spinal cord. Depending on the underlying cancer, disease distribution, CSF flow and overall condition, treatment may involve intrathecal medicine, systemic therapy, external beam radiotherapy or combinations of these approaches. Neurosurgery lists for selected CNS access sit on brain tumor surgery in India.

Other selected cancers

The route may occasionally be considered in other cancers with CNS or leptomeningeal involvement. The decision should always be made by a specialist familiar with the patient's cancer and CNS findings.

Medicines used in India

The specific drug is determined by cancer type and protocol.

Methotrexate

Methotrexate is one of the most commonly recognised medicines used for this route. It may appear in selected leukaemia and lymphoma protocols and in other situations where CNS-directed treatment is indicated.

Cytarabine

Cytarabine may also be administered into CSF in selected haematological malignancies. Some protocols use it alone; others combine medicines.

Hydrocortisone

Hydrocortisone may be included in certain triple regimens together with methotrexate and cytarabine. The exact combination is protocol-dependent.

Patients should not choose a drug based on price. Intrathecal medicines have specific dosing and administration requirements, and not every chemotherapy drug can safely be given this way. The treating team determines medicine, dose, frequency and duration.

What a session quotation may include

Before accepting a hospital quotation, ask for an itemised estimate. A comprehensive quotation may include some or all of the following:

Oncology consultation

The medical oncologist, haemato-oncologist or relevant specialist reviews the diagnosis and confirms the plan.

Pre-treatment investigations

Blood tests and other investigations may be required before administration. Depending on the diagnosis, these can include complete blood count, platelet count, kidney and liver function, coagulation tests, CSF analysis, CSF cytology, flow cytometry and imaging.

Lumbar puncture

For many patients, medicine is administered through a lumbar puncture. The procedure involves inserting a needle into the lower back to access CSF.

Chemotherapy medicine

The cost of the medication depends on the drug, formulation and dose.

Drug preparation and administration

Specialised preparation and administration may be billed separately depending on the hospital.

CSF testing

When clinically required, CSF may be analysed for cancer cells or other abnormalities.

Observation

Some hospitals include a period of observation after the procedure.

Supportive medicines

Additional medicines may be prescribed depending on symptoms and clinical situation.

What is usually not included

A low quoted price does not necessarily mean that complete treatment will be inexpensive. The following may be billed separately:

• Initial cancer consultation
• Diagnostic pathology and molecular testing
• Bone marrow examination
• MRI, CT or PET-CT
• CSF flow cytometry
• Hospital admission or ICU care
• Blood or platelet transfusions
• Antibiotics and treatment of infection
• Neurological investigations
• Ommaya reservoir placement and neurosurgery
• Other systemic chemotherapy, immunotherapy or targeted therapy
• Radiation therapy
• Travel and accommodation for international patients

Ask whether a quotation represents one administration or the complete oncology pathway.

Major factors affecting cost

Type of cancer

ALL, lymphoma, AML and leptomeningeal disease may involve different protocols, frequencies and monitoring.

Number of treatments

Some patients need a limited number of administrations. Others require repeated treatments over weeks or months.

Type of chemotherapy

Different drugs have different acquisition and preparation costs.

Lumbar puncture versus Ommaya reservoir

Repeated lumbar punctures may be suitable for some patients. An Ommaya reservoir may be considered when repeated CSF access is required. Because reservoir placement is a surgical procedure, it can change the overall cost substantially.

CSF testing

Patients may require repeated CSF testing to assess response or determine whether malignant cells remain detectable.

Hospital category

Costs can differ between government hospitals, charitable cancer centres, teaching hospitals, mid-range private hospitals and premium private hospitals.

Specialist fees

Haematology, medical oncology, neuro-oncology and neurosurgery expertise can influence the final bill.

Clinical condition

Patients with complications, low blood counts, infection or neurological problems may require additional investigations or hospitalisation.

Paediatric versus adult treatment

Children with leukaemia may follow highly structured paediatric oncology protocols. Their schedule and supportive-care requirements can differ substantially from adults. Neighbouring pediatric bone marrow transplantation is $28,000–$75,000 when a paediatric graft is named separately.

International patient requirements

International patients may have additional costs for records review, coordination, transfers, accommodation, visa documentation, translation, a longer stay in India and follow-up coordination. These should be separated from the medical treatment cost.

Lumbar-puncture administration

Lumbar puncture is one of the most common ways to administer this treatment.

The patient is positioned appropriately, and the lower back is cleaned using sterile precautions. Local anaesthesia may be used to numb the skin. A specialised needle is then inserted between the lower spinal bones into the CSF space. CSF may be collected for laboratory testing when required. The chemotherapy medicine is administered according to the prescribed protocol. The needle is removed and the patient is observed according to the hospital's protocol.

For many patients, the procedure is performed as day-care treatment rather than requiring a prolonged admission.

Ommaya-reservoir administration

An Ommaya reservoir is a small device implanted under the scalp and connected to the ventricular system of the brain. It can provide an alternative route for administering medication directly into CSF in selected patients.

It is not simply another type of injection. Placement requires a neurosurgical procedure, so the cost structure is very different from a standard lumbar puncture. The overall cost can include neurosurgeon consultation, preoperative investigations, operating-room charges, anaesthesia, the reservoir or device, surgical and nursing fees, hospital stay, postoperative monitoring and subsequent administrations.

Not every patient needs a reservoir. The decision is made by the treating team based on diagnosis, treatment frequency, anatomy, previous procedures and overall clinical circumstances.

Intrathecal versus intravenous chemotherapy

Feature	Intrathecal chemotherapy	Intravenous chemotherapy
Route	Directly into CSF	Into a vein
Main target	CNS / CSF	Systemic circulation
Common access	Lumbar puncture or Ommaya reservoir	IV cannula, PICC or port
Frequency	Protocol-dependent	Protocol-dependent
Typical use	Selected CNS-risk or CNS-involved cancers	Many types of cancer
Hospital setting	Often day-care	Day-care or inpatient
Drug selection	Limited to medicines suitable for the CSF route	Much broader range
Cost	Procedure + drug + monitoring	Drug + infusion + monitoring and other care

Intrathecal chemotherapy does not generally replace systemic chemotherapy when systemic treatment is required. In many plans the two approaches are complementary. Neighbouring chemotherapy remains $1,500–$8,000+ when the parent systemic protocol is named separately.

How many sessions are needed?

There is no universal number. The schedule depends on cancer type and subtype, CNS involvement, CSF findings, age, treatment response, risk classification, the systemic protocol, previous treatment and the presence or absence of neurological disease.

Certain leukaemia protocols may involve repeated administrations during different phases. In lymphoma, CNS prophylaxis may involve a defined number of administrations. In leptomeningeal disease, frequency may depend on whether malignant cells remain detectable and how the patient responds.

A patient should not estimate total cost simply by multiplying a generic per-session price by an assumed number of injections.

Intrathecal chemotherapy cost by Indian city

There is no reliable single national tariff, and hospitals frequently update procedure, drug and day-care charges. GAF Healthcare uses one national partner planning band of $3,000–$10,000 rather than inventing city-specific prices.

International patients comparing medical oncologists listing Intrathecal Chemotherapy commonly start with Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Partner medical oncology hospitals in Delhi NCR, Mumbai and Bengaluru, and in Chennai and Hyderabad, are a typical first filter. City sheets include Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad. Pune, Kolkata, Ahmedabad and Jaipur are not live GAF catalog cities on this site.

City	Catalogue doctors list	India planning band
Delhi NCR	Medical oncologists listing Intrathecal Chemotherapy	$3,000–$10,000
Mumbai	Medical oncologists listing Intrathecal Chemotherapy	$3,000–$10,000
Bengaluru	Medical oncologists listing Intrathecal Chemotherapy	$3,000–$10,000
Chennai	Medical oncologists listing Intrathecal Chemotherapy	$3,000–$10,000
Hyderabad	Medical oncologists listing Intrathecal Chemotherapy	$3,000–$10,000

These figures should not be interpreted as official city-specific hospital tariffs. The actual price may be lower or substantially higher depending on hospital, medicine, specialist, laboratory requirements and whether the patient requires hospitalisation.

A city-specific quotation should always be requested from the selected hospital.

India compared with other countries

India is often considered for cancer treatment because private healthcare costs can be lower than in many high-income countries. International comparisons can still be misleading.

One country's quoted price may include only the procedure, while another country's package may include consultation, chemotherapy, laboratory testing, hospitalisation and follow-up.

A proper comparison should consider the same cancer diagnosis, medicine, dose, number of administrations, access route, investigations, hospital stay, supportive care and follow-up period.

For international patients, the total cost of the cancer treatment plan is generally more meaningful than the price of a single injection. Neighbouring United States comparison figures on the GAF sheet are $15,000–$40,000.

Is the procedure safe?

It can be an important component of cancer treatment, but it is a specialised procedure with potential risks.

Possible complications and side effects may include headache, nausea, vomiting, back discomfort, dizziness, fever, infection, bleeding, chemical meningitis, neurological toxicity, seizures in rare situations and changes in neurological function.

The exact risks depend on the medicine, dose, treatment frequency, the patient's health and the route of administration. A patient should receive individualised counselling before treatment.

If severe or persistent headache, fever, confusion, new weakness, seizure, difficulty speaking, significant vomiting, severe back pain, loss of consciousness or other sudden neurological changes develop, seek a local emergency department immediately. Do not wait for a later clinic visit or use WhatsApp as emergency care.

What should patients ask before treatment?

1. What is the exact cancer diagnosis?
2. Why is this route being recommended?
3. Is it treatment or CNS prophylaxis?
4. Which drug will be administered, and at what dose?
5. How many administrations are expected?
6. Will treatment be through lumbar puncture or an Ommaya reservoir?
7. Is CSF testing included?
8. Are pathology or flow-cytometry tests required?
9. Is the chemotherapy drug included in the quotation?
10. Is the oncologist's fee included?
11. Is day-care included, and will hospitalisation be required?
12. What happens if complications occur?
13. What is the estimated total cost of the complete cancer treatment?

These questions can prevent significant differences between an initial estimate and the final hospital bill.

Documents required for an estimate

International patients should ideally provide complete medical records before requesting a quotation:

• Diagnosis and histopathology reports
• Immunohistochemistry report
• Bone marrow biopsy report, where applicable
• Flow-cytometry and molecular or genetic testing
• CSF reports
• MRI, CT or PET-CT reports
• Previous chemotherapy and radiation records
• Current medication list and recent blood reports
• Discharge summaries
• Doctor's treatment recommendation

Providing complete records allows the treating team to determine whether this route is appropriate and to estimate the likely pathway more accurately.

How to reduce unexpected costs

Patients should not choose cancer treatment based only on the lowest quoted price. Ask hospitals for an itemised estimate that clearly identifies consultation, procedure, drug, laboratory, imaging, day-care or admission, doctor fees, nursing, medical consumables, follow-up and additional likely costs.

For international patients, it is also useful to request separate estimates for medical treatment, hospital charges, accommodation, local transportation and expected duration of stay.

Is this treatment available in India?

Yes. It is performed in specialised oncology and haematology centres. Large cancer hospitals and tertiary-care centres generally have multidisciplinary teams that can coordinate medical oncology, haematology, paediatric oncology, neuro-oncology, neurosurgery, radiation oncology, pathology, radiology and critical care.

The most appropriate centre depends on the patient's diagnosis rather than simply the size of the hospital. For leukaemia and lymphoma, access to a strong haematology-oncology service may be particularly important. For leptomeningeal disease, multidisciplinary expertise involving medical oncology, neuro-oncology, radiation oncology and neurosurgery may be valuable.

How to choose a centre

Patients should select hospitals based on the specific expertise required for their cancer, rather than treating this as a standalone injection.

Important factors include medical oncology expertise, haematology expertise, paediatric oncology if applicable, neuro-oncology support, neurosurgery availability, radiation oncology, advanced pathology and flow cytometry, ICU facilities, blood bank, emergency support and international patient services.

A hospital that performs the injection should also be able to manage the underlying malignancy and potential complications when required.

Treatment process in India

Step 1: Medical-record review

The oncology team reviews the diagnosis, previous treatment, laboratory reports and imaging.

Step 2: Specialist consultation

A medical oncologist or haematologist determines whether this route is indicated.

Step 3: Treatment planning

The doctor identifies the medicine, dose, route and treatment schedule.

Step 4: Pre-treatment testing

Blood tests and other investigations are performed as clinically necessary.

Step 5: Lumbar puncture or reservoir access

The chemotherapy is delivered into CSF through the selected route.

Step 6: Observation

The patient is monitored following administration.

Step 7: Follow-up

Blood counts, neurological status and CSF findings may be monitored depending on the disease.

Step 8: Further sessions

Additional treatments are administered according to the disease-specific protocol.

How long does a visit take?

The actual administration may be relatively brief, but the complete hospital visit can take longer. Time may be required for registration, doctor assessment, blood tests, pharmacy preparation, lumbar puncture, CSF collection, drug administration, observation and discharge.

Many patients receive treatment through a day-care setting, but some patients may require admission depending on their clinical condition.

An Ommaya reservoir placement requires a separate surgical procedure and should not be confused with a routine session.

Recovery

Recovery depends on the medication, treatment route and individual patient. After a lumbar puncture, some patients may experience headache or local discomfort.

Patients should follow the treating team's instructions regarding hydration, activity, medicines and follow-up. Any significant or new neurological symptoms should be reported promptly.

Urgent local emergency assessment is necessary if the patient develops severe or persistent headache, fever, confusion, new weakness, seizure, difficulty speaking, significant vomiting, severe back pain, loss of consciousness or other sudden neurological changes.

International patients

India receives patients from Africa, the Middle East, Central Asia and other regions for specialised cancer treatment. Planning should begin before travel.

A typical process is: medical records → specialist review → treatment recommendation → cost estimate → hospital confirmation → travel planning → treatment → follow-up.

Patients should avoid travelling based solely on a generic internet price. The treating hospital should review records before confirming whether this route is indicated, which drug will be used, how many sessions may be required, whether lumbar puncture is appropriate, whether an Ommaya reservoir is required, expected hospital stay and approximate treatment cost.

Frequently asked questions

What is the cost of this pathway in India?

GAF Healthcare partner planning is $3,000–$10,000 for the named overall pathway, typically day-care lumbar puncture or Ommaya access. Neighbouring United States comparison figures are $15,000–$40,000. The total can be considerably higher when multiple administrations and broader cancer treatment are required.

What is the cost of intrathecal methotrexate?

The cost varies by hospital, dose, administration route, laboratory tests and other treatment requirements. A single session may sit inside the broader pathway band, but the actual quotation should be obtained from the treating hospital.

Is this expensive in India?

The procedure itself may be relatively affordable compared with the overall cost of cancer treatment. Repeated sessions, chemotherapy drugs, CSF testing, hospitalisation and treatment of the underlying cancer can substantially increase total expenditure.

How many sessions are needed?

There is no standard number. The number depends on cancer type, CNS involvement, treatment protocol and response.

Is this the same as a lumbar puncture?

No. A lumbar puncture is the procedure used to access CSF. Intrathecal chemotherapy is the administration of an anticancer medicine into CSF through that access.

Is the procedure painful?

A local anaesthetic may be used during lumbar puncture. Patients can experience pressure or discomfort, but experiences vary.

Does every leukaemia patient need this route?

No. The decision depends on leukaemia subtype, CNS risk, treatment protocol and individual clinical findings.

Is it used for lymphoma?

Yes. Selected lymphoma patients may receive it to treat CNS involvement or as CNS prophylaxis.

What is an Ommaya reservoir?

An Ommaya reservoir is an implanted device that provides access to ventricular CSF. It can be used for repeated intrathecal or intraventricular treatment in selected patients.

Is reservoir placement included in the cost?

Usually it should be considered a separate cost unless the hospital explicitly includes it in a treatment package. Reservoir placement involves neurosurgical and hospital charges.

Can this route cure cancer?

It is one component of treatment in selected cancers. Whether treatment can produce remission, long-term disease control or cure depends on the underlying cancer and its overall plan.

Can it be given with systemic chemotherapy?

Yes. In several protocols, CNS-directed therapy is combined with systemic chemotherapy or other cancer treatments.

How long does a visit take?

The actual procedure may be relatively short, but the total hospital visit can take several hours because of consultation, testing, drug preparation, procedure and observation.

Can international patients receive this treatment in India?

Yes, provided the treating hospital determines that the patient is medically suitable. International patients should send complete medical records before travelling.

Which city in India should patients consider?

There is no single city for every patient. Delhi NCR, Mumbai, Bengaluru, Chennai and Hyderabad have advanced oncology centres on the live catalogue. The choice depends on the patient's diagnosis and the specialist expertise required.

Why consider India for this pathway?

India has a large network of tertiary cancer centres across medical oncology, haematology, radiation oncology, paediatric oncology and surgical oncology.

For international patients, India may offer experienced oncology specialists, multidisciplinary cancer care, advanced diagnostic facilities, modern radiation therapy, haematology and bone marrow transplant services, advanced pathology and molecular testing, competitive private healthcare costs, international patient departments and treatment options across multiple hospital categories.

Patients should compare hospitals based on clinical expertise and the complete treatment plan, not cost alone.

How GAF Healthcare can help

GAF Healthcare helps international patients explore cancer treatment options in India by coordinating medical records, specialist opinions, hospital options and treatment estimates.

For a patient considering this pathway, the process can include collection of medical records, preliminary case assessment, identification of the appropriate oncology specialty, coordination with suitable hospitals, specialist review, treatment recommendation, estimated treatment cost, hospital coordination, travel and treatment assistance, and follow-up coordination.

A final hospital quotation is issued only after the treating medical team reviews the patient's clinical information.

What to send for a personalised estimate

To receive a more accurate estimate, send:

Diagnosis: Age: Country of residence: Previous treatment: Current treatment: CSF report: Bone marrow or pathology report: MRI, CT or PET reports: Current blood reports: Doctor's recommendation: Preferred city in India:

The more complete the medical information, the more useful the preliminary estimate is likely to be.

Key takeaways

• GAF Healthcare partner planning for this pathway is $3,000–$10,000, typically day-care lumbar puncture or Ommaya access.
• Neighbouring United States comparison figures are $15,000–$40,000.
• The price is not standardised across Indian hospitals.
• The chemotherapy drug, procedure, CSF testing and hospital charges all influence the final price.
• Several administrations may be required.
• An Ommaya reservoir can change the total treatment cost because surgical placement is involved.
• The route is used in selected leukaemia, lymphoma and CNS or leptomeningeal conditions.
• It is usually part of a broader cancer treatment plan.
• International patients should obtain a regimen-specific hospital quotation after medical-record review.
• The lowest price is not necessarily the best option; specialist expertise and comprehensive cancer support are important.
• Always confirm exactly what a hospital quotation includes before making travel or treatment decisions.

Medical disclaimer

This article is intended for general educational and treatment-cost planning purposes only. Intrathecal chemotherapy is a specialised cancer treatment and should only be administered under the supervision of a qualified oncology or haematology team.

Cost figures are indicative and may change according to hospital, city, cancer diagnosis, chemotherapy drug, dose, number of sessions, investigations, specialist fees, admission requirements and other clinical factors.

The information on this page does not constitute a diagnosis, prescription, treatment recommendation or guarantee of treatment outcome.

Patients should consult a qualified medical professional who has reviewed their medical records before deciding whether this route is appropriate.

Last reviewed: October 2026

Sources and references

1. National Cancer Institute (NCI) — Intrathecal chemotherapy definition
2. National Cancer Institute (NCI) — Adult acute lymphoblastic leukaemia treatment
3. National Cancer Institute (NCI) — Adult acute myeloid leukaemia treatment
4. National Cancer Institute (NCI) — Adult non-Hodgkin lymphoma treatment
5. National Cancer Institute (NCI) — Childhood acute lymphoblastic leukaemia treatment
6. National Cancer Institute (NCI) — Methotrexate sodium
7. Macmillan Cancer Support — How chemotherapy is given
8. GAF Healthcare cost sheet — Intrathecal Chemotherapy ($3,000–$10,000; day-care LP or Ommaya access)
9. Oxford Academic / Neuro-Oncology — Lumbar Ommaya reservoir and intrathecal drug delivery
10. GAF Healthcare — Neighbouring chemotherapy, immunotherapy, CAR-T and transplant planning sheets

Medical information should be interpreted in the context of current clinical guidelines and the individual patient's diagnosis. Published hospital and provider cost estimates are indicative and can change without notice.